nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—PDE5A—clitoris—ovarian cancer	0.24	0.765	CbGeAlD
Avanafil—CYP3A4—Topotecan—ovarian cancer	0.0898	0.354	CbGbCtD
Avanafil—CYP3A4—Vinorelbine—ovarian cancer	0.0633	0.249	CbGbCtD
Avanafil—CYP3A4—Paclitaxel—ovarian cancer	0.0445	0.175	CbGbCtD
Avanafil—CYP3A4—Docetaxel—ovarian cancer	0.0321	0.127	CbGbCtD
Avanafil—CYP3A4—Doxorubicin—ovarian cancer	0.024	0.0944	CbGbCtD
Avanafil—PDE5A—epithelium—ovarian cancer	0.0119	0.038	CbGeAlD
Avanafil—PDE5A—uterine cervix—ovarian cancer	0.0118	0.0377	CbGeAlD
Avanafil—PDE5A—gonad—ovarian cancer	0.00991	0.0316	CbGeAlD
Avanafil—PDE5A—female reproductive system—ovarian cancer	0.00885	0.0283	CbGeAlD
Avanafil—PDE5A—female gonad—ovarian cancer	0.00805	0.0257	CbGeAlD
Avanafil—PDE5A—vagina—ovarian cancer	0.008	0.0256	CbGeAlD
Avanafil—PDE5A—testis—ovarian cancer	0.00714	0.0228	CbGeAlD
Avanafil—PDE5A—lymph node—ovarian cancer	0.00518	0.0165	CbGeAlD
Avanafil—CYP3A4—female reproductive system—ovarian cancer	0.00276	0.00881	CbGeAlD
Avanafil—Constipation—Vinorelbine—ovarian cancer	0.000936	0.00216	CcSEcCtD
Avanafil—Immune system disorder—Paclitaxel—ovarian cancer	0.000936	0.00216	CcSEcCtD
Avanafil—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000934	0.00216	CcSEcCtD
Avanafil—Epistaxis—Docetaxel—ovarian cancer	0.000923	0.00213	CcSEcCtD
Avanafil—Asthenia—Topotecan—ovarian cancer	0.000918	0.00212	CcSEcCtD
Avanafil—Hot flush—Epirubicin—ovarian cancer	0.000915	0.00211	CcSEcCtD
Avanafil—Vomiting—Chlorambucil—ovarian cancer	0.000914	0.00211	CcSEcCtD
Avanafil—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000911	0.0021	CcSEcCtD
Avanafil—Mental disorder—Paclitaxel—ovarian cancer	0.000908	0.0021	CcSEcCtD
Avanafil—Menopausal symptoms—Epirubicin—ovarian cancer	0.000908	0.0021	CcSEcCtD
Avanafil—Pruritus—Topotecan—ovarian cancer	0.000905	0.00209	CcSEcCtD
Avanafil—Malnutrition—Paclitaxel—ovarian cancer	0.000902	0.00208	CcSEcCtD
Avanafil—Asthenia—Melphalan—ovarian cancer	0.000899	0.00208	CcSEcCtD
Avanafil—Pruritus—Melphalan—ovarian cancer	0.000886	0.00205	CcSEcCtD
Avanafil—Hypoglycaemia—Epirubicin—ovarian cancer	0.000877	0.00203	CcSEcCtD
Avanafil—Diarrhoea—Topotecan—ovarian cancer	0.000875	0.00202	CcSEcCtD
Avanafil—Back pain—Paclitaxel—ovarian cancer	0.000873	0.00201	CcSEcCtD
Avanafil—Urinary tract disorder—Docetaxel—ovarian cancer	0.000867	0.002	CcSEcCtD
Avanafil—Muscle spasms—Paclitaxel—ovarian cancer	0.000867	0.002	CcSEcCtD
Avanafil—Body temperature increased—Vinorelbine—ovarian cancer	0.000865	0.002	CcSEcCtD
Avanafil—Oedema peripheral—Docetaxel—ovarian cancer	0.000865	0.002	CcSEcCtD
Avanafil—Connective tissue disorder—Docetaxel—ovarian cancer	0.000863	0.00199	CcSEcCtD
Avanafil—Urethral disorder—Docetaxel—ovarian cancer	0.000861	0.00199	CcSEcCtD
Avanafil—Diarrhoea—Melphalan—ovarian cancer	0.000857	0.00198	CcSEcCtD
Avanafil—Pain in extremity—Epirubicin—ovarian cancer	0.000856	0.00198	CcSEcCtD
Avanafil—Nausea—Chlorambucil—ovarian cancer	0.000854	0.00197	CcSEcCtD
Avanafil—Vision blurred—Paclitaxel—ovarian cancer	0.00085	0.00196	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—ovarian cancer	0.000847	0.00196	CcSEcCtD
Avanafil—Dizziness—Topotecan—ovarian cancer	0.000846	0.00195	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00084	0.00194	CcSEcCtD
Avanafil—Agitation—Paclitaxel—ovarian cancer	0.000829	0.00191	CcSEcCtD
Avanafil—Eye disorder—Docetaxel—ovarian cancer	0.000821	0.0019	CcSEcCtD
Avanafil—Flushing—Docetaxel—ovarian cancer	0.000815	0.00188	CcSEcCtD
Avanafil—Cardiac disorder—Docetaxel—ovarian cancer	0.000815	0.00188	CcSEcCtD
Avanafil—Vomiting—Topotecan—ovarian cancer	0.000814	0.00188	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000812	0.00187	CcSEcCtD
Avanafil—Vertigo—Paclitaxel—ovarian cancer	0.00081	0.00187	CcSEcCtD
Avanafil—Rash—Topotecan—ovarian cancer	0.000807	0.00186	CcSEcCtD
Avanafil—Dermatitis—Topotecan—ovarian cancer	0.000806	0.00186	CcSEcCtD
Avanafil—Blood creatinine increased—Epirubicin—ovarian cancer	0.000802	0.00185	CcSEcCtD
Avanafil—Headache—Topotecan—ovarian cancer	0.000802	0.00185	CcSEcCtD
Avanafil—Palpitations—Paclitaxel—ovarian cancer	0.000797	0.00184	CcSEcCtD
Avanafil—Angiopathy—Docetaxel—ovarian cancer	0.000797	0.00184	CcSEcCtD
Avanafil—Vomiting—Melphalan—ovarian cancer	0.000797	0.00184	CcSEcCtD
Avanafil—Immune system disorder—Docetaxel—ovarian cancer	0.000793	0.00183	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—ovarian cancer	0.000792	0.00183	CcSEcCtD
Avanafil—Mediastinal disorder—Docetaxel—ovarian cancer	0.000792	0.00183	CcSEcCtD
Avanafil—Rash—Melphalan—ovarian cancer	0.00079	0.00182	CcSEcCtD
Avanafil—Dermatitis—Melphalan—ovarian cancer	0.000789	0.00182	CcSEcCtD
Avanafil—Cough—Paclitaxel—ovarian cancer	0.000787	0.00182	CcSEcCtD
Avanafil—Asthenia—Vinorelbine—ovarian cancer	0.000785	0.00181	CcSEcCtD
Avanafil—Hypertension—Paclitaxel—ovarian cancer	0.000779	0.0018	CcSEcCtD
Avanafil—Pruritus—Vinorelbine—ovarian cancer	0.000774	0.00179	CcSEcCtD
Avanafil—Breast disorder—Epirubicin—ovarian cancer	0.000774	0.00179	CcSEcCtD
Avanafil—Mental disorder—Docetaxel—ovarian cancer	0.000769	0.00178	CcSEcCtD
Avanafil—Chest pain—Paclitaxel—ovarian cancer	0.000768	0.00177	CcSEcCtD
Avanafil—Arthralgia—Paclitaxel—ovarian cancer	0.000768	0.00177	CcSEcCtD
Avanafil—Myalgia—Paclitaxel—ovarian cancer	0.000768	0.00177	CcSEcCtD
Avanafil—Nasopharyngitis—Epirubicin—ovarian cancer	0.000766	0.00177	CcSEcCtD
Avanafil—Malnutrition—Docetaxel—ovarian cancer	0.000765	0.00177	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000763	0.00176	CcSEcCtD
Avanafil—Nausea—Topotecan—ovarian cancer	0.00076	0.00175	CcSEcCtD
Avanafil—Gastritis—Epirubicin—ovarian cancer	0.000758	0.00175	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000755	0.00174	CcSEcCtD
Avanafil—Dry mouth—Paclitaxel—ovarian cancer	0.000751	0.00173	CcSEcCtD
Avanafil—Diarrhoea—Vinorelbine—ovarian cancer	0.000749	0.00173	CcSEcCtD
Avanafil—Nausea—Melphalan—ovarian cancer	0.000744	0.00172	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000742	0.00171	CcSEcCtD
Avanafil—Influenza—Epirubicin—ovarian cancer	0.00074	0.00171	CcSEcCtD
Avanafil—Back pain—Docetaxel—ovarian cancer	0.00074	0.00171	CcSEcCtD
Avanafil—Muscle spasms—Docetaxel—ovarian cancer	0.000735	0.0017	CcSEcCtD
Avanafil—Infection—Paclitaxel—ovarian cancer	0.000731	0.00169	CcSEcCtD
Avanafil—Dizziness—Vinorelbine—ovarian cancer	0.000724	0.00167	CcSEcCtD
Avanafil—Nervous system disorder—Paclitaxel—ovarian cancer	0.000722	0.00167	CcSEcCtD
Avanafil—Angina pectoris—Epirubicin—ovarian cancer	0.000721	0.00166	CcSEcCtD
Avanafil—Tachycardia—Paclitaxel—ovarian cancer	0.000719	0.00166	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—ovarian cancer	0.000716	0.00165	CcSEcCtD
Avanafil—Skin disorder—Paclitaxel—ovarian cancer	0.000715	0.00165	CcSEcCtD
Avanafil—Bronchitis—Epirubicin—ovarian cancer	0.000712	0.00164	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000709	0.00164	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—ovarian cancer	0.000701	0.00162	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000699	0.00161	CcSEcCtD
Avanafil—Vomiting—Vinorelbine—ovarian cancer	0.000696	0.00161	CcSEcCtD
Avanafil—Rash—Vinorelbine—ovarian cancer	0.00069	0.00159	CcSEcCtD
Avanafil—Dermatitis—Vinorelbine—ovarian cancer	0.000689	0.00159	CcSEcCtD
Avanafil—Hypotension—Paclitaxel—ovarian cancer	0.000688	0.00159	CcSEcCtD
Avanafil—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000688	0.00159	CcSEcCtD
Avanafil—Headache—Vinorelbine—ovarian cancer	0.000686	0.00158	CcSEcCtD
Avanafil—Influenza—Doxorubicin—ovarian cancer	0.000685	0.00158	CcSEcCtD
Avanafil—Pollakiuria—Epirubicin—ovarian cancer	0.000684	0.00158	CcSEcCtD
Avanafil—Palpitations—Docetaxel—ovarian cancer	0.000676	0.00156	CcSEcCtD
Avanafil—Weight increased—Epirubicin—ovarian cancer	0.000674	0.00156	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000671	0.00155	CcSEcCtD
Avanafil—Cough—Docetaxel—ovarian cancer	0.000667	0.00154	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—ovarian cancer	0.000667	0.00154	CcSEcCtD
Avanafil—Insomnia—Paclitaxel—ovarian cancer	0.000666	0.00154	CcSEcCtD
Avanafil—Hypertension—Docetaxel—ovarian cancer	0.00066	0.00152	CcSEcCtD
Avanafil—Infestation—Epirubicin—ovarian cancer	0.00066	0.00152	CcSEcCtD
Avanafil—Infestation NOS—Epirubicin—ovarian cancer	0.00066	0.00152	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—ovarian cancer	0.000659	0.00152	CcSEcCtD
Avanafil—Somnolence—Paclitaxel—ovarian cancer	0.000654	0.00151	CcSEcCtD
Avanafil—Arthralgia—Docetaxel—ovarian cancer	0.000651	0.0015	CcSEcCtD
Avanafil—Chest pain—Docetaxel—ovarian cancer	0.000651	0.0015	CcSEcCtD
Avanafil—Myalgia—Docetaxel—ovarian cancer	0.000651	0.0015	CcSEcCtD
Avanafil—Nausea—Vinorelbine—ovarian cancer	0.00065	0.0015	CcSEcCtD
Avanafil—Dyspepsia—Paclitaxel—ovarian cancer	0.000648	0.0015	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000646	0.00149	CcSEcCtD
Avanafil—Urinary tract infection—Epirubicin—ovarian cancer	0.000641	0.00148	CcSEcCtD
Avanafil—Dry mouth—Docetaxel—ovarian cancer	0.000637	0.00147	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000636	0.00147	CcSEcCtD
Avanafil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000636	0.00147	CcSEcCtD
Avanafil—Fatigue—Paclitaxel—ovarian cancer	0.000635	0.00147	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—ovarian cancer	0.000633	0.00146	CcSEcCtD
Avanafil—Constipation—Paclitaxel—ovarian cancer	0.00063	0.00145	CcSEcCtD
Avanafil—Haematuria—Epirubicin—ovarian cancer	0.000629	0.00145	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—ovarian cancer	0.000623	0.00144	CcSEcCtD
Avanafil—Epistaxis—Epirubicin—ovarian cancer	0.000622	0.00144	CcSEcCtD
Avanafil—Infection—Docetaxel—ovarian cancer	0.00062	0.00143	CcSEcCtD
Avanafil—Sinusitis—Epirubicin—ovarian cancer	0.000619	0.00143	CcSEcCtD
Avanafil—Nervous system disorder—Docetaxel—ovarian cancer	0.000612	0.00141	CcSEcCtD
Avanafil—Infestation—Doxorubicin—ovarian cancer	0.000611	0.00141	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—ovarian cancer	0.000611	0.00141	CcSEcCtD
Avanafil—Tachycardia—Docetaxel—ovarian cancer	0.000609	0.00141	CcSEcCtD
Avanafil—Skin disorder—Docetaxel—ovarian cancer	0.000606	0.0014	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—ovarian cancer	0.000594	0.00137	CcSEcCtD
Avanafil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000585	0.00135	CcSEcCtD
Avanafil—Oedema peripheral—Epirubicin—ovarian cancer	0.000584	0.00135	CcSEcCtD
Avanafil—Hypotension—Docetaxel—ovarian cancer	0.000583	0.00135	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—ovarian cancer	0.000582	0.00134	CcSEcCtD
Avanafil—Connective tissue disorder—Epirubicin—ovarian cancer	0.000582	0.00134	CcSEcCtD
Avanafil—Body temperature increased—Paclitaxel—ovarian cancer	0.000582	0.00134	CcSEcCtD
Avanafil—Urethral disorder—Epirubicin—ovarian cancer	0.000581	0.00134	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—ovarian cancer	0.000576	0.00133	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—ovarian cancer	0.000573	0.00132	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000569	0.00131	CcSEcCtD
Avanafil—Insomnia—Docetaxel—ovarian cancer	0.000564	0.0013	CcSEcCtD
Avanafil—Somnolence—Docetaxel—ovarian cancer	0.000555	0.00128	CcSEcCtD
Avanafil—Eye disorder—Epirubicin—ovarian cancer	0.000554	0.00128	CcSEcCtD
Avanafil—Cardiac disorder—Epirubicin—ovarian cancer	0.00055	0.00127	CcSEcCtD
Avanafil—Flushing—Epirubicin—ovarian cancer	0.00055	0.00127	CcSEcCtD
Avanafil—Dyspepsia—Docetaxel—ovarian cancer	0.000549	0.00127	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000541	0.00125	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—ovarian cancer	0.00054	0.00125	CcSEcCtD
Avanafil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000539	0.00124	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000539	0.00124	CcSEcCtD
Avanafil—Fatigue—Docetaxel—ovarian cancer	0.000538	0.00124	CcSEcCtD
Avanafil—Angiopathy—Epirubicin—ovarian cancer	0.000537	0.00124	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—ovarian cancer	0.000537	0.00124	CcSEcCtD
Avanafil—Immune system disorder—Epirubicin—ovarian cancer	0.000535	0.00124	CcSEcCtD
Avanafil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000534	0.00123	CcSEcCtD
Avanafil—Constipation—Docetaxel—ovarian cancer	0.000534	0.00123	CcSEcCtD
Avanafil—Asthenia—Paclitaxel—ovarian cancer	0.000528	0.00122	CcSEcCtD
Avanafil—Pruritus—Paclitaxel—ovarian cancer	0.000521	0.0012	CcSEcCtD
Avanafil—Mental disorder—Epirubicin—ovarian cancer	0.000519	0.0012	CcSEcCtD
Avanafil—Malnutrition—Epirubicin—ovarian cancer	0.000516	0.00119	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—ovarian cancer	0.000512	0.00118	CcSEcCtD
Avanafil—Flushing—Doxorubicin—ovarian cancer	0.000509	0.00117	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—ovarian cancer	0.000509	0.00117	CcSEcCtD
Avanafil—Diarrhoea—Paclitaxel—ovarian cancer	0.000504	0.00116	CcSEcCtD
Avanafil—Back pain—Epirubicin—ovarian cancer	0.000499	0.00115	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—ovarian cancer	0.000497	0.00115	CcSEcCtD
Avanafil—Muscle spasms—Epirubicin—ovarian cancer	0.000496	0.00114	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—ovarian cancer	0.000495	0.00114	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000494	0.00114	CcSEcCtD
Avanafil—Body temperature increased—Docetaxel—ovarian cancer	0.000493	0.00114	CcSEcCtD
Avanafil—Dizziness—Paclitaxel—ovarian cancer	0.000487	0.00112	CcSEcCtD
Avanafil—Vision blurred—Epirubicin—ovarian cancer	0.000486	0.00112	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—ovarian cancer	0.00048	0.00111	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—ovarian cancer	0.000477	0.0011	CcSEcCtD
Avanafil—Agitation—Epirubicin—ovarian cancer	0.000474	0.00109	CcSEcCtD
Avanafil—Vomiting—Paclitaxel—ovarian cancer	0.000468	0.00108	CcSEcCtD
Avanafil—Rash—Paclitaxel—ovarian cancer	0.000464	0.00107	CcSEcCtD
Avanafil—Dermatitis—Paclitaxel—ovarian cancer	0.000464	0.00107	CcSEcCtD
Avanafil—Vertigo—Epirubicin—ovarian cancer	0.000463	0.00107	CcSEcCtD
Avanafil—Back pain—Doxorubicin—ovarian cancer	0.000462	0.00107	CcSEcCtD
Avanafil—Headache—Paclitaxel—ovarian cancer	0.000461	0.00106	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—ovarian cancer	0.000459	0.00106	CcSEcCtD
Avanafil—Palpitations—Epirubicin—ovarian cancer	0.000456	0.00105	CcSEcCtD
Avanafil—Cough—Epirubicin—ovarian cancer	0.00045	0.00104	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—ovarian cancer	0.00045	0.00104	CcSEcCtD
Avanafil—Asthenia—Docetaxel—ovarian cancer	0.000448	0.00103	CcSEcCtD
Avanafil—Hypertension—Epirubicin—ovarian cancer	0.000445	0.00103	CcSEcCtD
Avanafil—Pruritus—Docetaxel—ovarian cancer	0.000441	0.00102	CcSEcCtD
Avanafil—Arthralgia—Epirubicin—ovarian cancer	0.000439	0.00101	CcSEcCtD
Avanafil—Chest pain—Epirubicin—ovarian cancer	0.000439	0.00101	CcSEcCtD
Avanafil—Myalgia—Epirubicin—ovarian cancer	0.000439	0.00101	CcSEcCtD
Avanafil—Agitation—Doxorubicin—ovarian cancer	0.000439	0.00101	CcSEcCtD
Avanafil—Nausea—Paclitaxel—ovarian cancer	0.000437	0.00101	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000436	0.00101	CcSEcCtD
Avanafil—Dry mouth—Epirubicin—ovarian cancer	0.000429	0.000992	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—ovarian cancer	0.000429	0.00099	CcSEcCtD
Avanafil—Diarrhoea—Docetaxel—ovarian cancer	0.000427	0.000986	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—ovarian cancer	0.000422	0.000974	CcSEcCtD
Avanafil—Infection—Epirubicin—ovarian cancer	0.000418	0.000966	CcSEcCtD
Avanafil—Cough—Doxorubicin—ovarian cancer	0.000416	0.000961	CcSEcCtD
Avanafil—Nervous system disorder—Epirubicin—ovarian cancer	0.000413	0.000953	CcSEcCtD
Avanafil—Dizziness—Docetaxel—ovarian cancer	0.000413	0.000953	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—ovarian cancer	0.000412	0.000951	CcSEcCtD
Avanafil—Tachycardia—Epirubicin—ovarian cancer	0.000411	0.000949	CcSEcCtD
Avanafil—Skin disorder—Epirubicin—ovarian cancer	0.000409	0.000944	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—ovarian cancer	0.000406	0.000938	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—ovarian cancer	0.000406	0.000938	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—ovarian cancer	0.000406	0.000938	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000403	0.000932	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—ovarian cancer	0.000397	0.000917	CcSEcCtD
Avanafil—Vomiting—Docetaxel—ovarian cancer	0.000397	0.000916	CcSEcCtD
Avanafil—Rash—Docetaxel—ovarian cancer	0.000393	0.000909	CcSEcCtD
Avanafil—Hypotension—Epirubicin—ovarian cancer	0.000393	0.000908	CcSEcCtD
Avanafil—Dermatitis—Docetaxel—ovarian cancer	0.000393	0.000908	CcSEcCtD
Avanafil—Headache—Docetaxel—ovarian cancer	0.000391	0.000903	CcSEcCtD
Avanafil—Infection—Doxorubicin—ovarian cancer	0.000387	0.000893	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000383	0.000885	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000382	0.000882	CcSEcCtD
Avanafil—Insomnia—Epirubicin—ovarian cancer	0.000381	0.000879	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—ovarian cancer	0.00038	0.000878	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—ovarian cancer	0.000378	0.000873	CcSEcCtD
Avanafil—Somnolence—Epirubicin—ovarian cancer	0.000374	0.000864	CcSEcCtD
Avanafil—Nausea—Docetaxel—ovarian cancer	0.000371	0.000856	CcSEcCtD
Avanafil—Dyspepsia—Epirubicin—ovarian cancer	0.00037	0.000856	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—ovarian cancer	0.000364	0.00084	CcSEcCtD
Avanafil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000363	0.000839	CcSEcCtD
Avanafil—Fatigue—Epirubicin—ovarian cancer	0.000363	0.000838	CcSEcCtD
Avanafil—Constipation—Epirubicin—ovarian cancer	0.00036	0.000831	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000355	0.000819	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—ovarian cancer	0.000352	0.000813	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—ovarian cancer	0.000346	0.000799	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—ovarian cancer	0.000343	0.000792	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000336	0.000776	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—ovarian cancer	0.000336	0.000775	CcSEcCtD
Avanafil—Constipation—Doxorubicin—ovarian cancer	0.000333	0.000769	CcSEcCtD
Avanafil—Body temperature increased—Epirubicin—ovarian cancer	0.000333	0.000768	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—ovarian cancer	0.000308	0.000711	CcSEcCtD
Avanafil—Asthenia—Epirubicin—ovarian cancer	0.000302	0.000697	CcSEcCtD
Avanafil—Pruritus—Epirubicin—ovarian cancer	0.000298	0.000688	CcSEcCtD
Avanafil—Diarrhoea—Epirubicin—ovarian cancer	0.000288	0.000665	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—ovarian cancer	0.000279	0.000645	CcSEcCtD
Avanafil—Dizziness—Epirubicin—ovarian cancer	0.000278	0.000643	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—ovarian cancer	0.000276	0.000636	CcSEcCtD
Avanafil—Vomiting—Epirubicin—ovarian cancer	0.000268	0.000618	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—ovarian cancer	0.000266	0.000615	CcSEcCtD
Avanafil—Rash—Epirubicin—ovarian cancer	0.000265	0.000613	CcSEcCtD
Avanafil—Dermatitis—Epirubicin—ovarian cancer	0.000265	0.000612	CcSEcCtD
Avanafil—Headache—Epirubicin—ovarian cancer	0.000264	0.000609	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—ovarian cancer	0.000258	0.000595	CcSEcCtD
Avanafil—Nausea—Epirubicin—ovarian cancer	0.00025	0.000577	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—ovarian cancer	0.000248	0.000572	CcSEcCtD
Avanafil—Rash—Doxorubicin—ovarian cancer	0.000246	0.000567	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—ovarian cancer	0.000245	0.000566	CcSEcCtD
Avanafil—Headache—Doxorubicin—ovarian cancer	0.000244	0.000563	CcSEcCtD
Avanafil—Nausea—Doxorubicin—ovarian cancer	0.000231	0.000534	CcSEcCtD
